Cross Country Healthcare, Inc. CCRN 深 沪
等待开盘 07-14 09:30:00 美东时间
13.22
0.000
0.00%
华盛通- 最 高13.23
- 今 开13.22
- 成交量 35.50万股
- 最 低 13.215
- 昨 收 13.22
- 总市值 4.27亿
- 52周最高 14.99
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 7.43
- 委 比 76.64%
- 总股本 3230.65万
- 历史最高 40.12
- 量 比 0.96
- 振 幅 0.11%
- 历史最低 3.76
- 每 手 1
- 风险率 2.06%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cross Country Healthcare Faces Challenges to Planned Merger
Cross Country Healthcare ( ($CCRN) ) just unveiled an update. On June 15, 2026,...
07-06 18:48
Cross Country Healthcare announces special shareholder meeting on merger approval
Cross Country Healthcare announces special shareholder meeting on merger approval Cross Country Healthcare will hold a special stockholder meeting in New York on July 16, 2026. Stockholders will vote on approving the proposed merger in which KL Criss Cross Merger Sub will merge into the company. The
07-06 18:18
KL十字交叉
核心事件：医疗人员配置服务商Cross Country Healthcare此前与直接竞争对手Aya Healthcare的收购案因反垄断审查终止，后续于20...
06-23 22:31
Cross Country Healthcare Advances Toward KL Criss Cross Merger
Cross Country Healthcare ( ($CCRN) ) has shared an announcement. Cross Country ...
06-23 21:30
Cross Country Healthcare says HSR waiting period expires for KKR deal
Cross Country Healthcare says HSR waiting period expires for KKR deal Cross Country Healthcare is set to be acquired by KL Criss Cross Intermediate through a merger, leaving the company as a wholly owned subsidiary. Regulatory waiting periods tied to the merger and the planned sale of Cross Country’
06-23 20:31
美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
05-12 12:36
Benchmark Downgrades Cross Country Healthcare to Hold
Benchmark analyst Bill Sutherland downgrades Cross Country Healthcare (NASDAQ:CCRN) from Buy to Hold.
05-09 03:56
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Agilon Health (NYSE:AGL) shares moved upwards by 115.7% to $60.08 duri...
05-08 01:05
Knox Lane To Acquire All Outstanding Shares Of Cross Country Healthcare Common Stock For $13.25/Shr In All-Cash Transaction Valued At $437M
Cross Country Healthcare, Inc. (NASDAQ:CCRN) ("Cross Country Healthcare" or the "Company") a leading, technology-driven healthcare workforce solutions company, today announced that it has entered into a definitive
05-07 05:35
